The Phia Group Webinars

As the dog days of summer drag on, the No Surprises Act and its benefactors are feeling the heat. Case volume is overloading the IDR process. Courts are split over whether and how parties can enforce arbitration awards. Payers, including…

We progressively find ourselves on the receiving end of both medical provider and legislative efforts to secure more funding from payers.  As costs increase, overpriced treatments gain popularity, and fallout from new laws continues to do more harm than good;…

During the COVID 19 pandemic, experts anticipated that we would see a surge in undiagnosed cancers.  That prediction proved to be accurate.  Driven by this ongoing issue, on March 8 the Biden Administration announced updates to its “Cancer Moonshot.”  Combining…

On Dec. 27, 2020, the No Surprises Act (NSA) was signed into law, with an eye towards protecting patients against so-called “surprise” balance bills.  The law leaned heavily on “good faith” negotiations between payers and providers, as well as “objective”…

From Contrave to Saxenda to Wegovy and beyond, society is being bombarded with messaging about weight loss drugs.  While many publicly debate their efficacy and long term viability, far fewer are openly asking who will pay for them – and…

In this first webinar of 2024, our crew will provide a rundown of 2024’s biggest plan document and stop-loss updates, including matters about which our team has been asked the most.  Stay ahead of the crowd, and join The Phia…